Oracle Health Sciences InForm Cloud Service 6.1 Helps Life Sciences Organizations Accelerate Study Start-Up and Expand Risk-Based Monitoring Precision

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. SPY
3. META
4. PSKY
5. VRTX
6. LGND
7. ONON
8. GS
9. MONC:IM
10. PTON

Go back to Oracle Health Sciences InForm Cloud Service 6.1 Helps Life Sciences Organizations Accelerate Study Start-Up and Expand Risk-Based Monitoring Precision

Wedbush Cuts Price Target Following Oracle (ORCL) EPS Miss

June 18, 2015 8:33 AM EDT

Wedbush maintains a Neutral rating on Oracle (NYSE: ORCL), and cut the price target to $40.00 (from $42.00), following F4Q results. ORCL reported EPS of $0.78 compared to $0.86 consensus. ORCL guided EPS to $0.56-$0.59.

Analyst Steve Koenig commented, "ORCL missed consensus... More

Cantor Fitzgerald Remains Bullish Following Oracle (ORCL) F4Q15 Results

June 18, 2015 8:12 AM EDT

Cantor Fitzgerald reiterates a Buy rating and $48.00 price target on Oracle (NYSE: ORCL) following F4Q15 results. EPS of $0.78 fell short of consensus at $0.86. Oracle expects nonGAAP sales to be up 5-8% YoY in CC and pro forma EPS in CC to be $0.56-0.59.... More

Jefferies Reiterates Hold Following Oracle (ORCL) F4Q Miss

June 18, 2015 7:36 AM EDT

Jefferies maintains a Hold rating and $41.00 price target on Oracle (NYSE: ORCL) following F4Q results. Reported Non-GAAP EPS of $0.78 was below consensus of $0.87. ORCL reported revenues of $10.706B, compared to $10.972B consensus.

Analyst John DiFucci commented, "ORCL reported F4Q results... More